Vedolizumab is safe and effective in moderate-to-severe inflammatory bowel disease following liver transplantation

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Vedolizumab is safe and effective in moderate-to-severe inflammatory bowel disease following liver transplantation
Authors
Keywords
-
Journal
LIVER TRANSPLANTATION
Volume 23, Issue 7, Pages 968-971
Publisher
Wiley
Online
2017-03-15
DOI
10.1002/lt.24757
References
View 4 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.